Prognostic Value of Biomarkers Associated With Endothelial Progenitor Cells Mobilization in Acute Coronary Syndromes
Not Applicable
Completed
- Conditions
- Acute Coronary Syndromes
- Registration Number
- NCT02117037
- Lead Sponsor
- Assistance Publique Hopitaux De Marseille
- Brief Summary
This prospective study aimed to validate a new prognostic approach of endothelial progenitor cells associated biomarkers in patients with acute coronary syndromes . Recruitment is made prospectively by two centers of Inter -region South Mediterranean,
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
- acute coronary syndrome (ST + < 12 hours and ST- high risk or intermediate risk ),which there is an indication of percutaneous coronary intervention.
Exclusion Criteria
- Cancer
- Chronic inflammatory disease
- Infectious disease
- Erythrocyte <4 G/l
- Thrombopénia less than 100 000/mm3 ;
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method evaluate the value of circulating endothelial progenitor cells quantification in the initial phase of ACS in predicting the occurrence of a major cardiovascular event (ECVM ) at 1 year. one year
- Secondary Outcome Measures
Name Time Method determine the technical characteristics (sensitivity and specificity) and predictive value of the number of PEC one day , one month , one year
Trial Locations
- Locations (1)
assistance Publique Hopitaux de Marseille
🇫🇷Marseille, France
assistance Publique Hopitaux de Marseille🇫🇷Marseille, France